TITLE

Low-intensity warfarin therapy prevented recurrent venous thromboembolism

AUTHOR(S)
Schulman, Sam
PUB. DATE
September 2003
SOURCE
ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p42
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study that investigated the effectiveness of low-intensity warfarin therapy in preventing recurrent venous thromboembolism. Design; Intervention; Outcome measures; Commentary.
ACCESSION #
10987126

 

Related Articles

  • High efficiency of low-dose warfarin ends blood-clot study.  // Geriatrics;Apr2003, Vol. 58 Issue 4, p9 

    Reports that an international study of low-dose warfarin confirmed its effectiveness in preventing the recurrence of deep vein thrombosis and pulmonary embolism. Duration and details of the clinical trial led by researchers from the Prevention of Recurrent Venous Thrombosis and Hemostasis,...

  • Evaluating costs of a pharmacist-run thromboprophylaxis program. Saltiel, Emmanuel; Shane, Rita // Formulary;Apr96, Vol. 31 Issue 4, p276 

    Presents a cost analysis of warfarin versus enoxaparin for deep venous thrombosis prophylaxis. Costs of a pharmacist-run thromboprophylaxis program; Warfarin dosing protocol development; Results of pharmacist-run warfarin-dosing protocol; Analysis of cost factors; Pulmonary embolism prophylaxis...

  • Study: Aspirin as effective as warfarin for prevention of blood clots after TJR. Parvizi, Javad // Orthopedics Today;Apr2013, Vol. 33 Issue 4, p22 

    The article reports that a study by Dr. Javad Parvizi and colleagues at the Rothman Institute in Philadelphia, Pennsylvania that revealed patients showing lower rates of pulmonary embolism if they took aspirin after a total joint replacement.

  • Oral anticoagulation: A review of the current and emerging therapies. McArthur, Mary C.; Dzintars, Elise K.; Bushardt, Reamer L. // JAAPA: Journal of the American Academy of Physician Assistants (;Nov2011, Vol. 24 Issue 11, p60 

    The article discusses the emerging therapies of oral anticoagulation. It notes that Dabigatran is the first oral direct thrombin inhibitor to be approved by the Food and Drug Administration and is used for the prevention of stroke and systematic embolism in patients with nonvalvular atrial...

  • Dabigatran versus Warfarin for Venous Thromboembolism. Peetz, Dirk; Lackner, Karl J. // New England Journal of Medicine;3/18/2010, Vol. 362 Issue 11, p1050 

    A letter to the editor is presented in response to an article about the use of the thrombin antagonist dabigatran and warfarin in treating acute venous thromboembolism by Sam Schulman in the December 10, 2009 issue.

  • Dabigatran versus Warfarin for Venous Thromboembolism. Teachey, David T. // New England Journal of Medicine;3/18/2010, Vol. 362 Issue 11, p1050 

    A letter to the editor is presented in response to an article about the use of the thrombin antagonist dabigatran and warfarin in treating acute venous thromboembolism by Sam Schulman in the December 10, 2009 issue.

  • Dabigatran versus Warfarin for Venous Thromboembolism. Schulman, Sam // New England Journal of Medicine;3/18/2010, Vol. 362 Issue 11, p1050 

    A response by Sam Schulman to a letter to the editor about an article on the use of the thrombin antagonist dabigatran and warfarin in treating acute venous thromboembolism in the December 10, 2009 issue is presented.

  • In real-world study, benefits outweigh risk for restarting warfarin after initial GI bleed. Walker, Tracey // Formulary;Nov2012, Vol. 47 Issue 11, p381 

    The article discusses research which was conducted by Daniel Witt and his colleagues at Kaiser Permanente Colorado in Aurora, Colorado and was published in a 2012 online issue of the "Archives of Internal Medicine". The research found that patients taking long-term warfarin who had bleeding in...

  • Deep venous thrombosis: Keeping clots in check. Vendatham, Suresh // Cortlandt Forum;Apr2006, Vol. 19 Issue 4, p40 

    The article offers information on managing and preventing the formation of deep venous thrombosis (DVT), the most common clinical manifestation of venous thromboembolism (VTE) that develops in the legs and arms. Initial treatment for DVT should include prevention of DVT propagation, relief of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics